🏥 CE-Ventures Invests in Oyster Therapeutics $60 Million Series A CE-Ventures has joined a $60 million funding round for UK-based Oyster Therapeutics. The capital will accelerate the clinical progression of oral brain-penetrant therapies for tau-driven diseases. 🔗 Read the full story on GazeWire
Private to this visit. Text and context are processed by AI.